Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Autologous ex-vivo-expanded peripheral polyclonal lymphocytes enriched in activated natural killer cells

EU orphan designation number: EU/3/17/1918   
Active ingredient: Autologous ex-vivo-expanded peripheral polyclonal lymphocytes enriched in activated natural killer cells
Indication: Treatment of multiple myeloma
Sponsor: CellProtect Nordic Pharmaceuticals AB
Hälsovägen 7, 141 57 Huddinge, Sverige

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
18/10/2017 Orphan designation EMA/OD/125/17 (2017)7051 of 16/10/2017